Background: Different drug-eluting stents may have different clinical efficacy in bifurcation interventions. Thus, we sought to compare the long term efficacy of sirolimus (SES) and everolimus (EES) eluting stents in patients with bifurcation lesions. Methods: We realized a cooperative, non-sponsored, pooled analysis on (previously ever unreported) long term outcome data from 2 prospective randomized trials with similar methodology (SEASIDE and CORPAL). In these trials, patients with all types of bifurcations were randomly assigned to treatment with either a SES (nϭ220) or EES (nϭ223) according to the provisional side-branch stenting technique. Primary end-point of the study was the occurrence of major adverse cardiac events (MACE) (death of any cause, acute myocardial infarction or repeat revascularization) during 3-year follow-up. Landmark analysis for late (Ͼ12 months) events was planned. Results: A total of 443 patients with bifurcated lesions were randomized to a SES (nϭ220) or EES (nϭ223). The two study group did not differed and, overall, 70.1% of patients had target bifurcation located in the distal left main or left anterior descending artery, 60.9% presented with acute coronary syndromes and 37.2% had Medina 1,1,1 lesion. Three-year follow-up was available in 439 (99.1%) of patients. At 3 years, MACE occurred in 7.7% of patients and were non-significantly lower in patients randomized to EES vs. SES: 6.8% vs. 8.7% (pϭ0.16). Interestingly, total mortality rate was 4.1% in SES group vs. 1.8% of EES group (pϭ0.14). At landmark analysis for late events, MACE occurring after 12-month were significantly reduced in patients randomized to EES compared to SES: 1.4% vs. 5.4% (pϭ0.02). Conclusions: Provisional side branch stenting with SES or EES in bifurcation lesions is associated with low rates of major adverse events at 3-year follow-up. Patients randomized to EES, as compared with SES, exhibited a numerically lower incidence of adverse events during the 3-year follow-up and a significantly lower rate of adverse late (beyond 1 year) adverse events.
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Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions (CBL) Treated With Drug Eluting Stents (DES)
Leonard Ngunga 1 , Po Kee Cheung 1 , Shantu Bundhoo 1 , Neil Brass 1 , Benjamin Tyrrell 1 , Raymond Leung 1 , Micha Dorsch 1 , William Hui 1 1 Royal Alexandra Hospital, Edmonton, Alberta Background: There is limited data on the long term outcomes of CBL treated with DES Methods: We examined the outcomes of patients with CBL treated with 1st and 2nd generation DES from 2002 to 2011. Clinical outcomes of TLR and mortality were collected from Alberta Provincial database and medical records. Outcomes for 1st generation DES (sirolimus-SES; paclitaxel-PES) and 2nd generation DES (everolimus-EES) were compared over 2 yrs while the 1st generation DES were compared over 8 yrs. Multivariate analysis was used to identify independent predictors of TLR Results: 829 patients (79% males; mean 62 yrs) underwent coronary stenting for 940 CBL of which 66% had side branch (SB) disease. Stent use was 43% SES, 29% PES, 25% EES. 32.2% of CBL with SB disease required SB stenting. At 2 yrs SES had lower TLR rate compared to PES (3.8%vs7.9%; pϭ0.004) and EES (3.8%vs5.5%; pϭ0.015) but similar survival rates SES 96.9%, PES 94.5%, EES 97.4%; pϭ0.298. Patients with SB disease undergoing SB stenting had higher TLR rates than those without SB stenting (9.1vs5.1%; pϭ0.044). SB stenting was an independent predictor of TLR (HR 17.5, 6.6 -46.1); pϽ0.00001. Over 8 yrs survival was similar between 1st generation DES; (SESvsPES; 97.0%vs94.6%; pϭ0.408). CABG rate was SES 2.5%, PES 2.3%, EES 0.8%, pϭ0.32. Definite stent thrombosis occurred in 0.74% of lesions over 8 yrs Conclusions: 1st and 2nd generation DES are effective in treatment of CBL with overall low rates of TLR at 2 yrs. SES have better long term outcomes compared to PES and EES in CBL. A single stent approach gives better long term outcomes compared to additional SB stenting
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Long Term Outcomes Of Two Stent Technique For The Treatment Of Complex Coronary Bifurcations In The Drug Eluting Stent (DES) Era -A Comparison Of Three Contemporary Strategies
Leonard Ngunga 1 , Shantu Bundhoo 1 , Po Kee Cheung 1 , Neil Brass 2 , Raymond Leung 1 , Benjamin Tyrrell 1 , Keysun Ranjbar 1 , Micha Dorsch 1 , William Hui 1 1 Royal Alexandra Hospital, Edmonton, Alberta, 2 Royal Alexandra Hospital, Edmonton, CA Background: While main branch (MB) stent with provisional side branch (SB) stenting is the preferred approach in the treatment of coronary bifurcations, not uncommonly a 2-stent strategy with SB stenting is required. We report the long-term outcomes of the 2-stent strategy for the treatment of coronary bifurcations using 3 contemporary techniques Methods: Data on coronary bifurcation stenting procedure details and clinical outcomes was collected from medical records and our provincial catheter laboratory database. We report the outcomes of 212 patients undergoing MB and SB stenting using DES where the 3 most frequently used techniques were Crush (CR -48.1%), Culotte (CU -22.6%) and T-Stent (TS -22.2%) TUESDAY, OCTOBER 23, 8:00 AM-10:00 AM 
